Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

MetLife Declares Preferred Stock Dividends for Multiple Series

MetLife, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on August 17, 2026, disclosing the declaration of preferred stock dividends across four series of its preferred equity.

Shwetambri Chauhan | 17 August 2026

Black Hills Files Merger Pro Forma Data With NorthWestern

Black Hills Corporation filed a Form 8-K with the SEC on August 17, 2026, providing historical financial statements of NorthWestern Energy Group, Inc. and unaudited pro forma combined financial information in connection with the companies' pending all-stock merger.

Shwetambri Chauhan | 17 August 2026

Lumentum Holdings Files Annual Report for Fiscal Year 2026

Lumentum Holdings Inc. filed its Annual Report on Form 10-K with the U.S. Securities and Exchange Commission on August 17, 2026, covering the fiscal year ended June 27, 2026.

Manish Choudhary | 17 August 2026

Insight Enterprises Director Sells 4,000 Shares

A Form 4 filed with the SEC on August 17, 2026, disclosed that Anthony Ibarguen, a director of Insight Enterprises Inc (NASDAQ:NSIT), sold 4,000 shares of common stock on August 13, 2026.

Shwetambri Chauhan | 17 August 2026

SimilarWeb CEO Exercises Options and Sells Shares

SimilarWeb Ltd. Chief Executive Officer filed a Form 4 on August 17, 2026, disclosing the exercise of stock options and the sale of ordinary shares on August 13 and August 14, 2026.

Aakashdeep | 17 August 2026

Dyne Therapeutics CEO Sells Shares for Tax Withholding

A Form 4 filed on August 17, 2026 reports that John Cox, CEO and President of Dyne Therapeutics, Inc. (NASDAQ:DYN), disposed of 4,986 shares of common stock on August 13, 2026 to satisfy tax withholding obligations tied to vesting restricted stock units.

Anjali Anand | 17 August 2026

Dyne Therapeutics CMO Sells 1,556 Shares for Tax Withholding

A Form 4 filed on August 17, 2026, disclosed that Douglas Kerr, Chief Medical Officer of Dyne Therapeutics, Inc. (NASDAQ:DYN), sold 1,556 shares of common stock on August 13, 2026, to satisfy tax withholding obligations tied to vesting restricted stock units.

Nitish Kishor | 17 August 2026

Dyne Therapeutics CCO Sells 226 Shares in Tax Withholding Transaction

Johanna Friedl-Naderer, Chief Commercial Officer of Dyne Therapeutics, Inc. (NASDAQ:DYN), filed a Form 4 on August 17, 2026, reporting an automatic sale of 226 shares of common stock on August 13, 2026, to satisfy tax withholding obligations tied to vesting restricted stock units.

Manish Choudhary | 17 August 2026

Intapp Chief Product Officer Sells 25,000 Shares

Thad Jampol, Chief Product Officer of Intapp, Inc. (NASDAQ:INTA), filed a Form 4 on August 17, 2026, disclosing the sale of 25,000 shares of common stock on August 13, 2026, pursuant to a pre-established 10b5-1 trading plan.

Aakashdeep | 17 August 2026

Intapp CFO Sells 20,000 Shares Under 10b5-1 Plan

David H. Morton Jr., Chief Financial Officer of Intapp, Inc. (NASDAQ:INTA), filed a Form 4 on August 17, 2026, disclosing the sale of 20,000 shares of common stock on August 13, 2026, executed under a pre-established Rule 10b5-1 trading plan.

Anjali Anand | 17 August 2026
Support

Hi! How can we help you today?

Loading…